A review questions whether psilocybin’s hallmark side effects, like visual changes and emotional upheaval, are truly necessary for its antidepressant effects. While some clinicians argue these experiences drive therapeutic breakthroughs, emerging evidence shows antidepressant-like benefits in animals through serotonin, opioid, and glutamate pathways independent of hallucinations.